Wittmann G, Szabon J, Mohcsik P, Nouriel SS, Gereben B, Fekete C, et al
Due to the legal landscape of peptides and research products, providing information that may imply anything beyond laboratory research use is a legal liability
Current UK law generally restricts all injectable products to POM status
Proper dose escalation to minimize side effects Nausea and fatigue, the symptoms often attributed to b12 needs, more commonly result from starting doses too high or escalating too quickly
Inflammation Modulation BPC-157-induced inflammation is supported by studies showing modulation of immune and inflammatory signaling pathways
Mechanism in research literature DSIP has no single established mechanism